(Q34113968)

31 July 2017

1 reference

title

Part VII. Treatment of Neuropsychiatric symptoms in Alzheimer's disease (English)

1 reference

31 July 2017

0 references

1

Knopman DS

1 reference

31 July 2017

1 November 2000

1 reference

31 July 2017

1 reference

31 July 2017

46

1 reference

31 July 2017

11

1 reference

31 July 2017

761-766

1 reference

Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Major depression in a population of demented and nondemented older people: prevalence and correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Depression in patients referred to a dementia clinic. A three-year prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Differences between patient and family assessments of depression in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

The course of psychopathologic features in mild to moderate Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Behavioral disturbance in dementia of the Alzheimer's type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

The spectrum of behavioral changes in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

7 January 2021

Assessment of agitation.

2 references

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

A metaanalysis of controlled trials of neuroleptic treatment in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Prospects for pharmacotherapy of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Risperidone for dementia-related disturbed behavior in nursing home residents: a clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Clozapine: a 2-year open trial in Parkinson's disease patients with psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

Assessment of depression in patients with Alzheimer's disease: Concordance among informants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2800%2990008-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0011-5029(00)90008-7

1 reference

31 July 2017

1 reference

PubMed ID

11130326